Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 3
2005 2
2007 1
2008 2
2010 2
2011 4
2012 9
2013 6
2014 7
2015 2
2016 6
2017 2
2018 4
2019 8
2020 9
2021 9
2022 5
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
mHealth Monitoring of Treatment of Cutaneous Leishmaniasis Patients: A Community-Based Implementation Study.
Cossio A, Bautista-Gomez MM, Alexander N, Del Castillo AM, Castro MDM, Castaño-Grajales PY, Gutiérrez-Poloche YH, Zuluaga LS, Vargas-Bernal L, Navarro A, Saravia NG. Cossio A, et al. Among authors: navarro a. Am J Trop Med Hyg. 2023 Aug 28;109(4):778-790. doi: 10.4269/ajtmh.22-0805. Print 2023 Oct 4. Am J Trop Med Hyg. 2023. PMID: 37640290 Free PMC article.
Randomized trial evaluating an mHealth intervention for the early community-based detection and follow-up of cutaneous leishmaniasis in rural Colombia.
Castillo M, Alexander N, Rubiano L, Rojas C, Navarro A, Rincon D, Bernal LV, Lerma YO, Saravia NG, Aronoff-Spencer E. Castillo M, et al. Among authors: navarro a. PLoS Negl Trop Dis. 2023 Mar 27;17(3):e0011180. doi: 10.1371/journal.pntd.0011180. eCollection 2023 Mar. PLoS Negl Trop Dis. 2023. PMID: 36972285 Free PMC article. Clinical Trial.
Number needed to treat and associated cost analysis of cenobamate versus third-generation anti-seizure medications for the treatment of focal-onset seizures in patients with drug-resistant epilepsy in Spain.
Villanueva V, Serratosa JM, Toledo M, Ángel Calleja M, Navarro A, Sabaniego J, Pérez-Domper P, Álvarez-Barón E, Subías S, Gil A. Villanueva V, et al. Among authors: navarro a. Epilepsy Behav. 2023 Feb;139:109054. doi: 10.1016/j.yebeh.2022.109054. Epub 2023 Jan 3. Epilepsy Behav. 2023. PMID: 36603345 Free article.
Determination of the economically justifiable price of cenobamate in the treatment of focal-onset seizures in adult patients with drug-resistant epilepsy in Spain.
Ángel Calleja M, Navarro A, Serratosa JM, Toledo M, Villanueva V, Subías Labazuy S, Gil A. Ángel Calleja M, et al. Among authors: navarro a. Expert Rev Pharmacoecon Outcomes Res. 2022 Oct;22(7):1127-1136. doi: 10.1080/14737167.2022.2107507. Epub 2022 Aug 3. Expert Rev Pharmacoecon Outcomes Res. 2022. PMID: 35904256 Free article.
Sensitivity and Specificity of the Remote Evaluation of Therapeutic Response in Cutaneous Leishmaniasis Using Photographs from a Mobile Application.
Del Castillo AM, Del Mar Castro M, Cossio A, García Luna JA, Rincón D, Castillo RM, Prieto MD, Rebellón-Sánchez DE, Navarro A, Alexander N. Del Castillo AM, et al. Among authors: navarro a. Am J Trop Med Hyg. 2022 Jul 25;107(3):662-8. doi: 10.4269/ajtmh.22-0164. Online ahead of print. Am J Trop Med Hyg. 2022. PMID: 35895332 Free PMC article.
Use of Generic Antiretroviral Drugs and Single-Tablet Regimen De-Simplification for the Treatment of HIV Infection in Spain.
Ruiz-Algueró M, Alejos B, García Yubero C, Riera Jaume M, Antonio Iribarren J, Asensi V, Pasquau F, Galera CE, Pascual-Carrasco M, Muñoz A, Jarrín I, Suárez-García I; CoRIS Cohort. Ruiz-Algueró M, et al. AIDS Res Hum Retroviruses. 2022 Jun;38(6):433-440. doi: 10.1089/AID.2021.0122. Epub 2022 May 2. AIDS Res Hum Retroviruses. 2022. PMID: 35357907
Aprotinin treatment against SARS-CoV-2: A randomized phase III study to evaluate the safety and efficacy of a pan-protease inhibitor for moderate COVID-19.
Redondo-Calvo FJ, Padín JF, Muñoz-Rodríguez JR, Serrano-Oviedo L, López-Juárez P, Porras Leal ML, González Gasca FJ, Rodríguez Martínez M, Pérez Serrano R, Sánchez Cadena A, Bejarano-Ramírez N, Muñoz Hornero C, Barberá Farré JR, Domínguez-Quesada I, Sepúlveda Berrocal MA, Villegas Fernández-Infantes MD, Manrique Romo MI, Parra Comino Á, Pérez-Ortiz JM, Gómez-Romero FJ; ATAC team. Redondo-Calvo FJ, et al. Eur J Clin Invest. 2022 Jun;52(6):e13776. doi: 10.1111/eci.13776. Epub 2022 Apr 5. Eur J Clin Invest. 2022. PMID: 35342931 Free PMC article. Clinical Trial.
Impact of the Addition of Baricitinib to Standard of Care Including Tocilizumab and Corticosteroids on Mortality and Safety in Severe COVID-19.
Masiá M, Padilla S, García JA, García-Abellán J, Navarro A, Guillén L, Telenti G, Mascarell P, Botella Á, Gutiérrez F. Masiá M, et al. Among authors: navarro a. Front Med (Lausanne). 2021 Nov 8;8:749657. doi: 10.3389/fmed.2021.749657. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34820393 Free PMC article.
74 results